in Parma, Italy, and again in 2024 for a. Pfizer API manufacturing plant.
If only life was so simple.Current concerns about low level impurities exacerbated by issues like the discovery of nitrosamine impurities in medicines.
2. , have led to a higher sensitivity to change and the risk of unknown threats.Unknowns are inertial (hence regulations can be enablers); and there are also clear opportunities and support to try and test new ideas and processes e.g.A combination of developing science and clear and joined up regulation e.g.
pharmacopeia and guidance, could help both the manufacturers and the biogenic solvent supply chain.Very clear and appropriate specifications and standards could help to accelerate the investment in and development of biogenic solvents, transitions, and approvals..
It was noted that there are streams of scientific development in Al models which can help predict the production of harmful impurities and detect these impurities cheaply at parts per billion and parts per trillion levels.. Standards are not just set by regulators.
Any party that sets specifications helps to create a myriad of different standards.As society’s requirement for data processing grows, so the market for data centres will continue to grow – and at a frantic pace.
The potential impact of our integrated approach, therefore, driving efficiency and improving performance, will only be more important for our clients and their customers..It is not sustainable, or desirable, to continue building more and more traditional data centres.
By ensuring that every element of these crucial facilities is viewed as an integral part of the whole, and by optimising all of them together, we will continue to work with our clients to ensure that the future of this market is a positive one.Jaimie Johnston MBE., Head of Global Systems at Bryden Wood, hosts.
(Editor: Quick Speakers)